Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.40 |
| ▸ | UBE2M | P61081 | 14/20 | 0.33 |
| ▸ | DCUN1D1 | Q96GG9 | 14/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18895968 | 0.92 | CCR1 (0.40) | CCR1UBE2MDCUN1D1CHRM2CCR5 | |
| SCHEMBL18633615 | 0.91 | CCR1 (0.39) | CCR1UBE2MDCUN1D1CHRM2CCR5 | |
| SCHEMBL15478324 | 0.90 | CCR1 (0.39) | CCR1CHRM2CCR5 | |
| SCHEMBL18633616 | 0.88 | CCR1 (0.36) | CCR1CHRM2CCR5 | |
| SCHEMBL18896015 | 0.88 | CCR1 (0.38) | CCR1CHRM2CCR5 | |
| SCHEMBL18633617 | 0.87 | CCR1 (0.41) | CCR1CHRM2CCR5 | |
| SCHEMBL18895961 | 0.87 | CCR1 (0.41) | CCR1CHRM2CCR5 | |
| SCHEMBL15478336 | 0.85 | CCR1 (0.58) | CCR1UBE2MDCUN1D1CHRM2CCR5 | |
| SCHEMBL656386 | 0.85 | CCR1 (0.58) | CCR1UBE2MDCUN1D1CHRM2CCR5 | |
| SCHEMBL18633618 | 0.85 | CCR1 (0.58) | CCR1UBE2MDCUN1D1CHRM2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663537-B2 | Chemokine receptor antagonists and methods of use | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2017-05-30 | — | — | US | disclosed |